Altimmune, Inc. Share Price
NASDAQ: ALT | Micro CapAltimmune, Inc. Stock Performance
Altimmune, Inc. Share Price Today
As of 29 October 2026, Altimmune, Inc.'s share price is $2.12. The stock opened at $2.12, compared to its previous close of $2.09. During today's trading session, Altimmune, Inc.'s share price traded between $2.10 and $2.14, with an average price of $2.12. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $2.00. In terms of performance, Altimmune, Inc.'s share price has declined by 18.02% over the last six months and is down 47.78% on a year-on-year basis.
Altimmune, Inc. Share Price Chart
Altimmune, Inc. Quarterly Profit & Loss
All figures in USD
Altimmune, Inc. Annual Profit & Loss
All figures in USD
About Altimmune, Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Altimmune, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.85 | $2.12 | -26.18% |
Sep 2026 | $3.08 | $2.87 | -11.71% |
Aug 2026 | $2.90 | $3.25 | +13.86% |
Jul 2026 | $3.06 | $2.85 | -5.79% |
Jun 2026 | $3.03 | $3.02 | -0.82% |
May 2026 | $2.57 | $3.05 | +18.22% |
Apr 2026 | $3.15 | $2.58 | -15.96% |
Mar 2026 | $4.22 | $3.07 | -28.77% |
Feb 2026 | $5.55 | $4.31 | -23.17% |
Jan 2026 | $3.62 | $5.61 | +55.62% |
Dec 2025 | $5.08 | $3.60 | -31.46% |
Nov 2025 | $4.02 | $5.26 | +29.88% |